Rush University Medical Center


 

2020 Update on EGFR+ mNSCLC: How Effective Is the Addition of Newly Approved Ramucirumab to Erlotinib? Results from the RELAY Study

494 views
September 11, 2020
Comments 0
Login to view comments. Click here to Login